Understand the optimal strategies to minimize complications during whole lung lavage (WLL), such as hypoxemia, fluid leakage, and barotrauma, as well as the absence of widely accepted protocols for patient positioning, chest percussion, and the use of extracorporeal membrane oxygenation (ECMO) in complex cases.
Learning Outcome(s):
- Explain the pathophysiological mechanisms underlying Pulmonary Alveolar Proteinosis (PAP), identify diagnostic indicators, and analyze the anesthetic considerations and multidisciplinary approaches required for whole lung lavage as a first-line treatment.
This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 Class A CE credits; Code Number 1045309; Expiration Date 2/12/2028. AANA designates this program as meeting the criteria for up to 1.0 CE Credits in pharmacology/therapeutics.